Delcath Systems
DCTH
15.38
-0.03
-0.19%
Delcath Systems
US · DCTH
#3706 by market cap
15.38
-0.03
-0.19%
Live - 5344 symbols - heartbeat 229s ago
· 2026-10-07 19:54
After-hours
15.38
0.00%
- Market cap
- 533.67M
- P/E (TTM)i
- 1,538.00
- P/Bi
- 4.41
- EPSi
- 0.07
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on DCTH?
Anonymous reader poll. Unscientific, not investment advice.
About Delcath Systems
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
- Founded
- 1988
- CEO
- Mr. Gerard J. Michel
- Employees
- 156
- Headquarters
- Queensbury, New York, United States of America
- Fiscal year end
- 12-31
- Website
- delcath.com
Company profile
- Exchange
- US
- Symbol
- DCTH
- Market-cap rank
- #3706
- Market cap
- 533.67M
- Float cap
- 442.60M
- Shares out
- 34.70M
- Float shares
- 28.78M
Sectors & themes
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.